First Time Loading...

Yield10 Bioscience Inc

Watchlist Manager
Yield10 Bioscience Inc Logo
Yield10 Bioscience Inc
Price: 2.8 USD +1.45% Market Closed
Updated: Jun 1, 2023

DCF Value

This DCF valuation model was created by Alpha Spread and was last updated on Apr 29, 2023.

Estimated DCF Value of one YTEN stock is 2.04 USD. Compared to the current market price of 2.8 USD, the stock is Overvalued by 27%.

Base Case
2.04 USD
Overvaluation 27%
DCF Value
Worst Case
Base Case
Best Case
DCF Value
Worst Case
Base Case
Best Case
DCF Value: 2.04 USD
Yield10 Bioscience Inc Competitors:
DCF Valuation
Exelixis Inc
Aveo Pharmaceuticals Inc
argenx SE
Clinuvel Pharmaceuticals Ltd
eFFECTOR Therapeutics Inc
Janux Therapeutics Inc
Akeso Inc

Present Value Calculation

The first step in the DCF calculation process is to estimate the company's future free cash flow. Once free cash flow is forecasted, it is discounted at a risk-appropriate discount rate. The resulting value is the present value of the company's free cash flow. You can change any model inputs below.

Available Valuation Models
1 valuation model available
Alpha Spread
Updated on Apr 29, 2023
Default Valuation
Create My Valuation Model
Other investors haven't shared any valuation models for Yield10 Bioscience Inc.
Model Settings
Operating Model
Equity Model: via Net Income
Discount Rate
Forecast Period
5 Years
Terminal Growth
Discount Rate
Terminal Growth
Growth Period
5 Years
Copy as My Model

DCF Model
Base Case Scenario

Rotate your device to view
DCF Model

To view the process of deriving the DCF Value of one share from the estimated Present Value, see the DCF Value Calculation block.

DCF Value Calculation

Depending on which type of operating model is chosen (equity or whole firm valuation model), the resulting value is either the value of equity or the value of the entire firm. In the case of the latter, to move from the value of the firm to the value of equity, liabilities are subtracted and assets are added.

Capital Structure
From Present Value to DCF Value

Present Value 12.3M USD
Equity Value 12.3M USD
/ Shares Outstanding 6M
YTEN DCF Value 2.04 USD
Overvalued by 27%

To view the process of calculating the Present Value of Yield10 Bioscience Inc' future free cash flow, see the Present Value Calculation block.

Valuation Analysis

After the valuation process, in order to gain a deeper understanding of the relationship between risk and opportunity, it is useful to study the dynamic of company's valuation under various inputs to the DCF model in use.

DCF Financials
Financials used in DCF Calculation

2.5M 175M
Net Income
-8.7M 3.5M
-8.7M 3.5M

Sensitivity Analysis
DCF Value Sensitivity Analysis

See Also

Similar Stocks
What is the DCF value of one YTEN stock?

Estimated DCF Value of one YTEN stock is 2.04 USD. Compared to the current market price of 2.8 USD, the stock is Overvalued by 27%.

The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock DCF values gives a complete picture of the investment risks and opportunities.

How was the DCF Value calculated?

1. Present Value Calculation. Using the DCF Operating Model we project Yield10 Bioscience Inc's future free cash flow and discount it at a selected discount rate to calculate its Present Value (12.3M USD).

2. DCF Value Calculation. We use the company's capital structure to calculate the total Equity Value based on the previously computed Present Value of the free cash flow. Dividing the Equity Value by the number of shares outstanding gives us the DCF Value of 2.04 USD per one YTEN share.